Equitable Holdings, Inc. Eli Lilly & CO Transaction History

Equitable Holdings, Inc.

$9.13 Billion
Q2 2024

A detailed history of Equitable Holdings, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Equitable Holdings, Inc. holds 14,557 shares of LLY stock, worth $11.3 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

14,557

Previous 13,924 4.55%

Holding current value

$11.3 Million

Previous $10.8 Million 21.67%

% of portfolio

0.14%

Previous 0.13%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $458,842 - $575,422	633 Added 4.55%	14,557 $13.2 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $1.76 Million - $2.35 Million	2,965 Added 27.06%	13,924 $10.8 Million
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $768,878 - $906,406	1,464 Added 15.42%	10,959 $6.39 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $25,647 - $35,358	-59 Reduced 0.62%	9,495 $5.1 Million
Q2 2023 Aug 15, 2023	BUY	$350.74 - $468.98 $461,924 - $617,646	1,317 Added 15.99%	9,554 $4.48 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $971,650 - $1.14 Million	3,128 Added 61.23%	8,237 $2.83 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $26,045 - $30,348	81 Added 1.61%	5,109 $1.87 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $306,560 - $349,357	1,034 Added 25.89%	5,028 $1.63 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $153,022 - $179,671	-549 Reduced 12.08%	3,994 $1.3 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $80,733 - $100,331	-344 Reduced 7.04%	4,543 $1.3 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $136,708 - $169,656	608 Added 14.21%	4,887 $1.35 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $443 - $545	-2 Reduced 0.05%	4,279 $989,000
Q2 2021 Aug 11, 2021	BUY	$180.55 - $233.54 $88,288 - $114,201	489 Added 12.9%	4,281 $983,000
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $109,272 - $141,458	665 Added 21.27%	3,792 $708,000
Q4 2020 Feb 09, 2021	BUY	$130.46 - $172.63 $12,132 - $16,054	93 Added 3.07%	3,127 $528,000
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $22,371 - $25,876	153 Added 5.31%	3,034 $449,000
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $30,694 - $36,940	225 Added 8.47%	2,881 $473,000
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $26,786 - $33,153	225 Added 9.26%	2,656 $368,000
Q4 2019 Feb 18, 2020	BUY	$106.92 - $132.43 $259,922 - $321,937	2,431 New	2,431 $320,000

Others Institutions Holding LLY

# of Institutions

3,916

Shares Held

765M

Call Options Held

6.34M

Put Options Held

7.96M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $738B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitable Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Equitable Holdings, Inc. with notifications on news.

Account

Equitable Holdings, Inc. Eli Lilly & CO Transaction History